Patents/Assignees

CELLECTIS SA

3 patents in portfolio

US12133867utility2024
Universal Anti-cd22 Chimeric Antigen Receptor Engineered Immune Cells
0 cites
US11944643utility2024
Universal Anti-cd22 Chimeric Antigen Receptor Engineered Immune Cells
0 cites
US11690873utility2023
Universal Chimeric Antigen Receptor T Cells Specific for CD22
0 cites